Home›People›Timothy Ladin
TL

Timothy Ladin

Chief Legal Officer at Illexcor Therapeutics.

Executive
Updated Nov 10, 2026·Latest SEC filing May 8, 2026·Suggest an edit

About Timothy Ladin

Timothy Ladin is a chief legal officer at Illexcor Therapeutics.

Experience

This experience comes from Timothy Ladin's profile and from SEC filings. For roles taken from filings, the years are when the filings name Timothy Ladin in the role, so the role may have started earlier or lasted longer.

Illexcor Therapeutics, Inc. Current
Chief Legal Officer
2025 – Present · Henrico, VA
Develops an oral drug for people with sickle cell disease.
Ladin Venture Advisors, LLC Current
Chief Executive Officer
2025 – Present
Herald Capital LLC Current
Managing Director
2025 – Present
CLEU Diagnostics Current
Chairman of the Board and Chief Legal Officer
2023 – Present
Parvizi Surgical Innovation Current
Board Member and Chief Legal Officer
2020 – Present
Unite Us Current
Board Member/Board Observer
2013 – Present
K2 Integrity Current
Senior Advisor
2010 – Present
Decisive Point
Investment Committee Member
2021 – 2025
Madison Realty Capital Equity Fund I, LLC
Investment Committee Member
2016 – 2025
Liquidnet Holdings, Inc.
Shareholder Representative
2020 – 2024
The Hearst Corporation
Counsel
2000 – 2007
Clifford Chance, Rogers & Wells
Associate
1995 – 2000

Key Colleagues at Startups

The people Timothy Ladin works with at each company, as listed on that company's latest Form D.

Illexcor Therapeutics, Inc. · Form D, May 8, 2026
AF
Andrew Fleischman
CEO and director
TL
Ted Love
Director

Sources

  1. SECIllexcor Therapeutics, Inc. Form D, filed May 8, 2026